NCI | Technology Transfer

Prevention Of Tumor Recurrence Through Inhibition Of Fibrosis, Integrin Signaling, Src And ERK Activation And Actin Stress Fiber Formation.

Read more about Prevention Of Tumor Recurrence Through Inhibition Of Fibrosis, Integrin Signaling, Src And ERK Activation And Actin Stress Fiber Formation.

US Application 61/179,641
Filed on 2009-05-19

Development Of Peptide Mimetic Ligands Of Polo-like Kinase L Polo Box Domain

Read more about Development Of Peptide Mimetic Ligands Of Polo-like Kinase L Polo Box Domain

US Application 61/178,593
Filed on 2009-05-15

Combination Immunotherapy Compositions And Methods

Read more about Combination Immunotherapy Compositions And Methods

US Application 61/170,530
Filed on 2009-04-17

The Natural Product Schweinfurthin A And Synthetic Schweinfurthin Analogs Specifically Inhibit NF1-null Cells And May Be Useful As A Therapy For Neurofibromatosis Type 1.

Read more about The Natural Product Schweinfurthin A And Synthetic Schweinfurthin Analogs Specifically Inhibit NF1-null Cells And May Be Useful As A Therapy For Neurofibromatosis Type 1.

US Application 61/174,338
Filed on 2009-04-30

Inhibitors Of FKBP52-Mediated Regulation Of Androgen Receptor Function

Read more about Inhibitors Of FKBP52-Mediated Regulation Of Androgen Receptor Function

US Application 61/242,541
Filed on 2009-09-15

A Dual Function Protein, ATIA, Is A Novel Diagnostic Marker For Human Glioblastoma And A Potential Therapeutic Target For Treating The Disease

Read more about A Dual Function Protein, ATIA, Is A Novel Diagnostic Marker For Human Glioblastoma And A Potential Therapeutic Target For Treating The Disease

US Application 61/182,072
Filed on 2009-05-28

A Panel Of Fully Human Monoclonal Antibodies To The Same Epitope Of An Unknown Cell Surface Antigen Expressed In B-cell Lymphocytic Leukemia (B-CLL)

Read more about A Panel Of Fully Human Monoclonal Antibodies To The Same Epitope Of An Unknown Cell Surface Antigen Expressed In B-cell Lymphocytic Leukemia (B-CLL)

US Application 61/178,688
Filed on 2009-05-15

Methods Of Preparing Lymphocytes That Express Interleukin-12 And Their Use In The Treatment Of Cancer

Read more about Methods Of Preparing Lymphocytes That Express Interleukin-12 And Their Use In The Treatment Of Cancer

US Application 61/174,046
Filed on 2009-04-30

Mutation Of Critcal Lysines In The LAT Adapter Molecular Leads To Enhance T Cell Signalling

Read more about Mutation Of Critcal Lysines In The LAT Adapter Molecular Leads To Enhance T Cell Signalling

US Application 61/176,231
Filed on 2009-05-07

Granulysin Immunotherapy

Read more about Granulysin Immunotherapy

US Application 61/250,601
Filed on 2009-10-12

Subscribe to NCI